Last update:

Immunology news

Oncology & Cancer

Precision therapy could stop breast cancer at the source

Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and difficult-to-treat forms of ...

Oncology & Cancer

What are the big unanswered questions about cancer? Experts discuss

Over the 40-year history of the University of Colorado Cancer Center, its investigators have answered many questions about cancer—what causes it, how to prevent it, and how to treat it. Those discoveries have helped many ...

Immunology

Common cold virus may unlock better COVID vaccine

Prior exposure to coronaviruses that cause ordinary colds can boost the immune system's ability to attack a vulnerable site on the COVID-19-causing coronavirus SARS-CoV-2, according to a study led by investigators at Weill ...

Diseases, Conditions, Syndromes

Scientists tie lupus to a virus nearly all of us carry

One of humanity's most ubiquitous infectious pathogens bears the blame for the chronic autoimmune condition called systemic lupus erythematosus (lupus), Stanford Medicine investigators and their colleagues have found.

Immunology

Flu vaccine performance varies by age, study reveals

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune system that help to protect against infection varied greatly depending on the vaccine type and age ...

Immunology

How the microbiome and a fiber-rich diet help fight melanoma

Scientists at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) have uncovered how the gut microbiota help the immune system fight melanoma, explaining why patients with a fiber-rich diet and balanced ...

Diseases, Conditions, Syndromes

Efanesoctocog alfa not cost-effective for prophylaxis in hemophilia A

For U.S. patients with severe hemophilia A, prophylaxis with efanesoctocog alfa is neither conventionally nor distributionally cost-effective, according to a study published online April 22 in the Annals of Internal Medicine.

Immunology

Q&A: Scientist explains how she created 'invisible' stem cells

One continuing challenge is the need to suppress transplant patients' immune systems to prevent their bodies from rejecting the transplant. Genetic engineering to prevent rejection has long been viewed as the "holy grail" ...

Oncology & Cancer

Study identifies how malaria can lead to childhood cancer

New data published in The Journal of Immunology has revealed the role of Plasmodium falciparum infection (malaria) in the development of Burkitt lymphoma (BL), the most common childhood cancer in equatorial Africa and New ...

Oncology & Cancer

Smoldering multiple myeloma: What it is and how it progresses

Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal plasma cells accumulate, they crowd out healthy cells and cause symptoms such as bone pain and tiredness.

Oncology & Cancer

Two-phase vaccination can boost the immune system against cancer

Our body's own defense system not only clears away bacteria and viruses, it can also fight cancer. However, not all tumor cells are easily recognizable by the immune system. In addition, they are constantly changing and camouflaging ...

Immunology

B cells found to be crucial for long-term vaccine protection

Researchers at the University of Colorado Anschutz Medical Campus have uncovered a critical, previously underappreciated role for B cells in vaccine protection. Best known for producing antibodies, B cells also guide other ...